Group visits: Promoting adherence to diabetes guidelines

Dawn E. Clancy, Peng Huang, Eni Okonofua, Derik Yeager, Kathryn Marley Magruder

Research output: Contribution to journalArticle

Abstract

BACKGROUND: Current diabetes management guidelines offer blueprints for providers, yet type 2 diabetes control is often poor in disadvantaged populations. The group visit is a new treatment modality originating in managed care for efficient service delivery to patients with chronic health problems. Group visits offer promise for delivering care to diabetic patients, as visits are lengthier and can be more frequent, more organized, and more educational. OBJECTIVE: To evaluate the effect of group visits on clinical outcomes, concordance with 10 American Diabetes Association (ADA) guidelines [American Diabetes Association, Diabetes Care, 28:S4-36, 2004] and 3 United States Preventive Services Task Force (USPSTF) cancer screens [U.S. Preventive Services Task Force, http://www.ahrq.gov/clinic/uspstf/resource.htm, 2003]. RESEARCH DESIGN AND METHODS: A 12-month randomized controlled trial of 186 diabetic patients comparing care in group visits with care in the traditional patient-physician dyad. Clinical outcomes (HbA1c, blood pressure [BP], lipid profiles) were assessed at 6 and 12 months and quality of care measures (adherence to 10 ADA guidelines and 3 USPSTF cancer screens) at 12 months. RESULTS: At both measurement points, HbA1c, BP, and lipid levels did not differ significantly for patients attending group visits versus those in usual care. At 12 months, however, patients receiving care in group visits exhibited greater concordance with ADA process-of-care indicators (p

Original languageEnglish (US)
Pages (from-to)620-624
Number of pages5
JournalJournal of General Internal Medicine
Volume22
Issue number5
DOIs
StatePublished - May 2007
Externally publishedYes

Fingerprint

Advisory Committees
Guidelines
Patient Care
Blood Pressure
Lipids
compound A 12
Quality of Health Care
Managed Care Programs
Vulnerable Populations
Type 2 Diabetes Mellitus
Neoplasms
Research Design
Randomized Controlled Trials
Physicians
Health
Population
Therapeutics

Keywords

  • Group visits
  • Guideline concordance
  • Type 2 diabetes control

ASJC Scopus subject areas

  • Internal Medicine
  • Medicine(all)

Cite this

Group visits : Promoting adherence to diabetes guidelines. / Clancy, Dawn E.; Huang, Peng; Okonofua, Eni; Yeager, Derik; Magruder, Kathryn Marley.

In: Journal of General Internal Medicine, Vol. 22, No. 5, 05.2007, p. 620-624.

Research output: Contribution to journalArticle

Clancy, Dawn E. ; Huang, Peng ; Okonofua, Eni ; Yeager, Derik ; Magruder, Kathryn Marley. / Group visits : Promoting adherence to diabetes guidelines. In: Journal of General Internal Medicine. 2007 ; Vol. 22, No. 5. pp. 620-624.
@article{85f0d33633c64c5fbe25d63ec09e57a5,
title = "Group visits: Promoting adherence to diabetes guidelines",
abstract = "BACKGROUND: Current diabetes management guidelines offer blueprints for providers, yet type 2 diabetes control is often poor in disadvantaged populations. The group visit is a new treatment modality originating in managed care for efficient service delivery to patients with chronic health problems. Group visits offer promise for delivering care to diabetic patients, as visits are lengthier and can be more frequent, more organized, and more educational. OBJECTIVE: To evaluate the effect of group visits on clinical outcomes, concordance with 10 American Diabetes Association (ADA) guidelines [American Diabetes Association, Diabetes Care, 28:S4-36, 2004] and 3 United States Preventive Services Task Force (USPSTF) cancer screens [U.S. Preventive Services Task Force, http://www.ahrq.gov/clinic/uspstf/resource.htm, 2003]. RESEARCH DESIGN AND METHODS: A 12-month randomized controlled trial of 186 diabetic patients comparing care in group visits with care in the traditional patient-physician dyad. Clinical outcomes (HbA1c, blood pressure [BP], lipid profiles) were assessed at 6 and 12 months and quality of care measures (adherence to 10 ADA guidelines and 3 USPSTF cancer screens) at 12 months. RESULTS: At both measurement points, HbA1c, BP, and lipid levels did not differ significantly for patients attending group visits versus those in usual care. At 12 months, however, patients receiving care in group visits exhibited greater concordance with ADA process-of-care indicators (p",
keywords = "Group visits, Guideline concordance, Type 2 diabetes control",
author = "Clancy, {Dawn E.} and Peng Huang and Eni Okonofua and Derik Yeager and Magruder, {Kathryn Marley}",
year = "2007",
month = "5",
doi = "10.1007/s11606-007-0150-3",
language = "English (US)",
volume = "22",
pages = "620--624",
journal = "Journal of General Internal Medicine",
issn = "0884-8734",
publisher = "Springer New York",
number = "5",

}

TY - JOUR

T1 - Group visits

T2 - Promoting adherence to diabetes guidelines

AU - Clancy, Dawn E.

AU - Huang, Peng

AU - Okonofua, Eni

AU - Yeager, Derik

AU - Magruder, Kathryn Marley

PY - 2007/5

Y1 - 2007/5

N2 - BACKGROUND: Current diabetes management guidelines offer blueprints for providers, yet type 2 diabetes control is often poor in disadvantaged populations. The group visit is a new treatment modality originating in managed care for efficient service delivery to patients with chronic health problems. Group visits offer promise for delivering care to diabetic patients, as visits are lengthier and can be more frequent, more organized, and more educational. OBJECTIVE: To evaluate the effect of group visits on clinical outcomes, concordance with 10 American Diabetes Association (ADA) guidelines [American Diabetes Association, Diabetes Care, 28:S4-36, 2004] and 3 United States Preventive Services Task Force (USPSTF) cancer screens [U.S. Preventive Services Task Force, http://www.ahrq.gov/clinic/uspstf/resource.htm, 2003]. RESEARCH DESIGN AND METHODS: A 12-month randomized controlled trial of 186 diabetic patients comparing care in group visits with care in the traditional patient-physician dyad. Clinical outcomes (HbA1c, blood pressure [BP], lipid profiles) were assessed at 6 and 12 months and quality of care measures (adherence to 10 ADA guidelines and 3 USPSTF cancer screens) at 12 months. RESULTS: At both measurement points, HbA1c, BP, and lipid levels did not differ significantly for patients attending group visits versus those in usual care. At 12 months, however, patients receiving care in group visits exhibited greater concordance with ADA process-of-care indicators (p

AB - BACKGROUND: Current diabetes management guidelines offer blueprints for providers, yet type 2 diabetes control is often poor in disadvantaged populations. The group visit is a new treatment modality originating in managed care for efficient service delivery to patients with chronic health problems. Group visits offer promise for delivering care to diabetic patients, as visits are lengthier and can be more frequent, more organized, and more educational. OBJECTIVE: To evaluate the effect of group visits on clinical outcomes, concordance with 10 American Diabetes Association (ADA) guidelines [American Diabetes Association, Diabetes Care, 28:S4-36, 2004] and 3 United States Preventive Services Task Force (USPSTF) cancer screens [U.S. Preventive Services Task Force, http://www.ahrq.gov/clinic/uspstf/resource.htm, 2003]. RESEARCH DESIGN AND METHODS: A 12-month randomized controlled trial of 186 diabetic patients comparing care in group visits with care in the traditional patient-physician dyad. Clinical outcomes (HbA1c, blood pressure [BP], lipid profiles) were assessed at 6 and 12 months and quality of care measures (adherence to 10 ADA guidelines and 3 USPSTF cancer screens) at 12 months. RESULTS: At both measurement points, HbA1c, BP, and lipid levels did not differ significantly for patients attending group visits versus those in usual care. At 12 months, however, patients receiving care in group visits exhibited greater concordance with ADA process-of-care indicators (p

KW - Group visits

KW - Guideline concordance

KW - Type 2 diabetes control

UR - http://www.scopus.com/inward/record.url?scp=34250310045&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250310045&partnerID=8YFLogxK

U2 - 10.1007/s11606-007-0150-3

DO - 10.1007/s11606-007-0150-3

M3 - Article

C2 - 17443369

AN - SCOPUS:34250310045

VL - 22

SP - 620

EP - 624

JO - Journal of General Internal Medicine

JF - Journal of General Internal Medicine

SN - 0884-8734

IS - 5

ER -